CLOV
Clover Health Investments, Corp. (CLOV)
Last Price$3.4(0.9%)
Market Cap$1,625.6M
$1,371.1M
-6.0% YoY
($43.0M)
-79.8% YoY
($221.5M)
Net Debt to FCF - (6.7x)
$33.3M
2.4% margin

CLOV Income Statement

CLOV Income Statement Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
$1,371.1M 8.8% YoY
$364.8M 42.5% YoY
26.6% margin
Cost of revenue
$1,006.3M 0.2% YoY
Operating expenses
$410.6M (11.0%) YoY
Net income
$43.0M (79.8%) YoY
(3.1%) margin
Other: $41.4M
SG&A
$408.9M (7.1%) YoY
29.8% of revenue

CLOV Income statement key metrics

Annual
Quarterly
LTM

Revenue

$1,371.1M +8.8% YoY

Operating Income

($45.7M) -77.7% YoY

Net Income

($43.0M) -79.8% YoY

CLOV Balance Sheet

CLOV Balance Sheet Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Assets
Liabilities
Total assets
$580.7M
Current assets ($343.1M, 59.1% of total)
$221.5M (38.1%)
Other current assets
$121.6M (20.9%)
Non-current assets ($237.6M, 40.9% of total)
$201.7M (34.7%)
$2,990.0K (0.5%)
Other non-current assets
$27.6M (4.8%)
Financial position
($221.5M)
$221.5M$0.0
Cash & Short-term Investments
Total Debt

CLOV Balance Sheet Metrics

Annual
Quarterly
LTM

Assets

$580.7M +1.8% YoY

Liabilities

$239.6M -15.7% YoY

Shareholder's Equity

$341.1M +19.1% YoY

CLOV Cash Flow Statement

CLOV Cash Flow Statement Overview

Annual
Quarterly
LTM
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Dec'24
Cash Beginning of PeriodOperating Cash FlowInvesting Cash FlowFinancing Cash FlowForex Changes on CashCash End of Period$176.5M$34.8M$565.0K($17.4M)$0.0$194.5M

CLOV Cash Flow Statement key metrics

Annual
Quarterly
LTM

Capital Expenditure (CAPEX)

($1,556.0K) +166.4% YoY

Free Cash Flow (FCF)

$33.3M N/A YoY

CLOV Financials

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
% growth
281.0
0.0%
462.3
64.5%
672.9
45.6%
1,472.0
118.8%
1,096.6
(25.5%)
1,260.5
15.0%
1,371.1
8.8%
Cost of Goods Sold (COGS)0.0449.7590.11,551.2993.11,004.61,006.3
% margin
281.0
100.0%
12.6
2.7%
82.8
12.3%
(79.2)
(5.4%)
103.5
9.4%
256.0
20.3%
364.8
26.6%
Operating Expenses476.0195.8175.5557.8390.1461.3410.6
Research & Development Expenses (R&D)0.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)187.3187.3192.1445.7482.4440.2408.9
(185.8)
(66.1%)
(183.2)
(39.6%)
(92.7)
(13.8%)
(637.0)
(43.3%)
(286.7)
(26.1%)
(205.3)
(16.3%)
(45.7)
(3.3%)
Interest Income7.00.00.10.00.00.00.0
Interest Expense0.039.157.116.91.40.00.0
Pre-tax Income(201.9)(363.7)(136.4)(587.8)(254.6)(210.1)(46.3)
% effective tax rate
(16.1)
8.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
0.0
0.0%
% margin
(201.9)
(71.9%)
(363.7)
(78.7%)
(136.4)
(20.3%)
(587.8)
(39.9%)
(339.6)
(31.0%)
(213.4)
(16.9%)
(43.0)
(3.1%)
EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
Diluted EPS(4.81)(0.90)(0.23)(1.25)(0.71)(0.45)(0.08)
% margin
(16.1)
(5.7%)
(324.1)
(70.1%)
(78.7)
(11.7%)
(569.6)
(38.7%)
(252.0)
(23.0%)
(207.6)
(16.5%)
(44.9)
(3.3%)